Janssen submits European extension marketing authorisation application for paliperidone palmitate

First long-acting treatment to be administered four times a year for the treatment of schizophrenia in adults
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Clinical trials Practical therapeutics Psychiatry Patient care antipsychotic Latest News long-acting therapy paliperidone palmitate schizophrenia xeplion Source Type: news